Clinical applications of molecular biomarkers in urothelial carcinoma of bladder.
- Author:
Liang CHENG
1
;
Jia-wen XU
;
Jia-jia HE
;
Jing ZHAO
;
Xiao-dong TENG
Author Information
1. liang_cheng@yahoo.com
- Publication Type:Journal Article
- MeSH:
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Basigin;
analysis;
Biomarkers, Tumor;
analysis;
genetics;
Carcinoma, Transitional Cell;
drug therapy;
genetics;
metabolism;
Gene Expression Profiling;
Humans;
In Situ Hybridization, Fluorescence;
Inhibitor of Apoptosis Proteins;
analysis;
Mutation;
Neoplasm Recurrence, Local;
metabolism;
Nuclear Proteins;
analysis;
Receptor, Fibroblast Growth Factor, Type 3;
analysis;
genetics;
Tumor Suppressor Protein p53;
analysis;
genetics;
Urinary Bladder Neoplasms;
drug therapy;
genetics;
metabolism
- From:
Chinese Journal of Pathology
2011;40(10):714-717
- CountryChina
- Language:Chinese
